The PI3K-Akt-mTOR signaling pathway is one of the most extensively investigated intracellular signaling cascades involved in tumor (12), while PI3K-Akt/NF-κB/ T-cell receptor (TCR) pathway participates in immunomodulation (9). This evidence concerns the gene AKT1 and neoplasm.